Patusky Christopher

United Therapeutics Corp.

Director

Avg. Two Year Performance

(7%) Avg. Purchase Return (3%) Compound

(18%) Avg. Sale Return (9%) Compound

Holdings: 1.1K shares

Last Three Months: 16-Feb-24 -- 15-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Insider Trading Sentiment: Reduce

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions